OPNT logo

Opiant Pharmaceuticals (OPNT) Accounts Payable

OPNT Annual Accounts Payable

$3.37 M
+$403.30 K+13.60%

31 December 2021

OPNT Accounts Payable Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

OPNT Quarterly Accounts Payable

$3.11 M
+$11.70 K+0.38%

30 September 2022

OPNT Quarterly Accounts Payable Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

OPNT Accounts Payable Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+13.6%+20.6%
3 y3 years+197.4%+59.5%
5 y5 years+6.7%+146.1%

OPNT Accounts Payable High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year
5 y5-year
alltimeall timeat high-41.5%

Opiant Pharmaceuticals Accounts Payable History

DateAnnualQuarterly
Sept 2022
-
$3.11 M(+0.4%)
June 2022
-
$3.10 M(-41.7%)
Mar 2022
-
$5.32 M(+57.8%)
Dec 2021
$3.37 M(+13.6%)
$3.37 M(+30.6%)
Sept 2021
-
$2.58 M(+5.5%)
June 2021
-
$2.45 M(-33.5%)
Mar 2021
-
$3.68 M(+24.1%)
Dec 2020
$2.97 M(+125.3%)
$2.97 M(+16.2%)
Sept 2020
-
$2.55 M(+79.8%)
June 2020
-
$1.42 M(-2.1%)
Mar 2020
-
$1.45 M(+10.2%)
Dec 2019
$1.32 M(+16.2%)
$1.32 M(-32.5%)
Sept 2019
-
$1.95 M(+81.8%)
June 2019
-
$1.07 M(-27.5%)
Mar 2019
-
$1.48 M(+30.8%)
Dec 2018
$1.13 M(-64.1%)
$1.13 M(-14.0%)
Sept 2018
-
$1.32 M(-40.0%)
June 2018
-
$2.19 M(-37.9%)
Mar 2018
-
$3.54 M(+179.4%)
Dec 2017
$3.16 M(+42.7%)
-
Oct 2017
-
$1.26 M(-42.8%)
July 2017
$2.21 M(+1473.3%)
$2.21 M(+59.0%)
Apr 2017
-
$1.39 M(+83.9%)
Jan 2017
-
$756.20 K(+17.9%)
Oct 2016
-
$641.50 K(+356.3%)
July 2016
$140.60 K
$140.60 K(-32.0%)
Apr 2016
-
$206.80 K(+487.5%)
Jan 2016
-
$35.20 K(-67.1%)
DateAnnualQuarterly
Oct 2015
-
$107.10 K(-66.1%)
July 2015
$315.50 K(+57.3%)
$315.50 K(+315.1%)
Apr 2015
-
$76.00 K(-2.1%)
Jan 2015
-
$77.60 K(+8.2%)
Oct 2014
-
$71.70 K(-64.3%)
July 2014
$200.60 K(+391.7%)
$200.60 K(+950.3%)
Apr 2014
-
$19.10 K(+45.8%)
Jan 2014
-
$13.10 K(-46.1%)
Oct 2013
-
$24.30 K(-40.4%)
July 2013
$40.80 K(-26.5%)
$40.80 K(-43.3%)
Apr 2013
-
$71.90 K(+18.8%)
Jan 2013
-
$60.50 K(+2.9%)
Oct 2012
-
$58.80 K(+5.9%)
July 2012
$55.50 K(-46.7%)
$55.50 K(-50.1%)
Apr 2012
-
$111.20 K(+166.7%)
Jan 2012
-
$41.70 K(+52.2%)
Oct 2011
-
$27.40 K(-73.7%)
July 2011
$104.10 K(-48.9%)
$104.10 K(0.0%)
Apr 2011
-
$104.10 K(-55.5%)
Jan 2011
-
$233.90 K(0.0%)
Oct 2010
-
$233.90 K(+14.7%)
July 2010
$203.90 K(>+9900.0%)
$203.90 K(+142.4%)
Apr 2010
-
$84.10 K(-49.2%)
Jan 2010
-
$165.40 K(>+9900.0%)
Oct 2009
-
$1100.00(>+9900.0%)
July 2009
$0.00(-100.0%)
$0.00(-100.0%)
Oct 2008
-
$23.90 K(+62.6%)
July 2008
$14.70 K(+390.0%)
$14.70 K(+390.0%)
July 2007
$3000.00
$3000.00

FAQ

  • What is Opiant Pharmaceuticals annual accounts payable?
  • What is the all time high annual accounts payable for Opiant Pharmaceuticals?
  • What is Opiant Pharmaceuticals annual accounts payable year-on-year change?
  • What is Opiant Pharmaceuticals quarterly accounts payable?
  • What is the all time high quarterly accounts payable for Opiant Pharmaceuticals?
  • What is Opiant Pharmaceuticals quarterly accounts payable year-on-year change?

What is Opiant Pharmaceuticals annual accounts payable?

The current annual accounts payable of OPNT is $3.37 M

What is the all time high annual accounts payable for Opiant Pharmaceuticals?

Opiant Pharmaceuticals all-time high annual accounts payable is $3.37 M

What is Opiant Pharmaceuticals annual accounts payable year-on-year change?

Over the past year, OPNT annual accounts payable has changed by +$403.30 K (+13.60%)

What is Opiant Pharmaceuticals quarterly accounts payable?

The current quarterly accounts payable of OPNT is $3.11 M

What is the all time high quarterly accounts payable for Opiant Pharmaceuticals?

Opiant Pharmaceuticals all-time high quarterly accounts payable is $5.32 M

What is Opiant Pharmaceuticals quarterly accounts payable year-on-year change?

Over the past year, OPNT quarterly accounts payable has changed by +$532.20 K (+20.62%)